News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc - Microbiome Research Supports Use of Steriwave
Ondine Biomedical's research at the SPIE Photonics West conference shows that its Steriwave® Nasal Photodisinfection System significantly reduces nasal pathogens without causing long-term harm to the nasal microbiome, offering a non-selective method of nasal decolonization with rapid recovery of the native microbiome post-treatment -
COMMUNIQUÉ DE PRESSE
Ondine Unveils New Research at SPIE Photonics West
Ondine Biomedical Inc. will present new research on photodisinfection and nasal decolonization at the SPIE Photonics West conference in San Francisco, California. The presentation will showcase the effectiveness of Steriwave as a nasal decolonization method. -
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc. Announces Appointment of new Chief Financial Officer
Ondine Biomedical Inc., a Canadian life sciences company, has appointed Joseph P. Errico as Chief Financial Officer. With a background in founding and selling medical device and pharmaceutical companies, Errico brings valuable experience in finance, capital markets, and developing medtech companies. His appointment comes at a crucial time as Ondine pursues international expansion and FDA approval. Errico's educational background includes a degree in Aeronautical Engineering from MIT and graduate degrees in Law and Mechanical/Materials Engineering from Duke University. Ondine Biomedical Inc. is innovating in photodisinfection therapies with products approved in multiple jurisdictions. For further information, please visit www.rns.com. -
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc Announces C$4.91 Raise Supports Ongoing Commercialisation
